Related Experiment Videos
[Perspectives on postgenome medicine: Neurological disorders]
1Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 24, 2001
Summary
Scientific research in the post-genome era focuses on gene function and disease treatment. Advances in human molecular genetics are key to developing molecular therapies for neurological disorders.
Area of Science:
- Molecular biology and genetics
- Neuroscience and neurodegenerative diseases
Context:
- The post-human genome era necessitates deeper analysis of gene products and biological phenomena.
- Human molecular genetics offers significant potential for understanding and treating neurological disorders.
Purpose:
- To analyze molecular structure and function of gene products.
- To elucidate the molecular pathophysiology of neurological disorders.
- To develop novel molecular therapies for human diseases, particularly neurological conditions.
Summary:
- Research aims to understand gene product functions and complex biological processes.
- Progress in human molecular genetics is crucial for advancing neuroscience and neurological disease research.
- Molecular therapy development requires integrating gene therapy, stem cell transplantation, and evidence-based drug design.
Impact:
- Facilitates the elucidation of molecular pathophysiology in neurological disorders.
- Enables the development of targeted molecular therapies for complex diseases.
- Integrates cutting-edge techniques like gene therapy and stem cell transplantation for therapeutic innovation.